Latest News about VIRX
Recent news which mentions VIRX
Stocks That Hit 52-Week Lows On Friday
May 05, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 26, 2023
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 14, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 27, 2023
From Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
From Benzinga
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
January 09, 2023
From Benzinga
From InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 09, 2022
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
Viracta Obtains Orphan Drug Status From European Commission For T-cell Lymphoma Candidate
September 07, 2022
Tickers
VIRX
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 08, 2022
From Benzinga
From Benzinga
79 Biggest Movers From Yesterday
June 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
May 16, 2022
From Benzinga
68 Biggest Movers From Yesterday
April 19, 2022
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 18, 2022
From Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
From Benzinga
64 Biggest Movers From Yesterday
March 18, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 07, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 31, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
From Benzinga
63 Biggest Movers From Yesterday
December 31, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 30, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 23, 2021
From Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.